Special Issue "The Application of Imaging (MALDI-MSI) in Human Carcinomas for the Identification of New Diagnostic Markers"
Deadline for manuscript submissions: closed (31 July 2022) | Viewed by 8105
Interests: thyroid carcinoma
Special Issues, Collections and Topics in MDPI journals
Special Issue in Journal of Personalized Medicine: Advances in Personalized Treatment of Cancer (Powered By: 4oncommunity)
Special Issue in Cells: Predictive Molecular and Integrative Pathology in Thyroid Carcinoma
MALDI-MSI has emerged as an influential analytical tool in clinical research and, in particular, it has proved to be a particularly useful technique for tissue-based research of tumor biology. Continuing improvements in technology have allowed the identification of biomarkers that may act as predictive or prognostic factors and are highly important for maximizing survival rates of cancer patients. On the other side, MALDI-MSI also provides insight into the mechanism of different types of cancers and an understanding of their pathogenesis and might become imperative for establishing diagnosis. This Special Issue will highlight applications of imaging MALDI-MSI for the identification of diagnostic-significant players for various types of cancers.
Prof. Fabio Pagni
Prof. Stefania Galimberti
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- diagnostic biomarker